Aristada aripiprazole lauroxil regulatory update

Alkermes submitted an sNDA to FDA for a 2-month dosing interval of Aristada aripiprazole lauroxil to treat schizophrenia. Aristada is already approved for once monthly or once every 6 week dosing. The...